German BioTech iDEL Therapeutics lands €9 million to develop cancer therapeutics platform
German BioTech iDEL Therapeutics lands €9 million to develop cancer therapeutics platform Dortmund-based iDEL Therapeutics announced the closing of a €9 million Seed financing, to develop a pipeline of cancer therapeutics that are delivered directly into the cytosol of tumor cells. The financing was led by BiomedVC with participation from

